Globe Life Beats Q1 Estimates and Raises FY26 EPS Guidance on Robust Underwriting Momentum

*

Quarter Overview

Globe Life’s Q1 earnings release showed a double‑digit rise in both net income per diluted share ($3.39, +13% YoY) and net operating income per diluted share ($3.43, +12% YoY). Return on equity slipped modestly to 17.9% from 19.0% a year ago, while the net‑operating‑income ROE (ex‑AOCI) held steady at 14.0%. Book value per share surged 19% to $77.03, and $98.56 when adjusted for accumulated other comprehensive income, reflecting the firm’s disciplined capital management.

*

Capital Allocation

The company continued its aggressive share‑repurchase program, buying back 1.4 million shares for $203 million during the quarter. At the current market price of $151.21, the repurchase represents roughly 1.1% of outstanding shares, a move that both boosts EPS and signals confidence in the balance sheet.

*

Segment Performance – Life vs. Health

Life insurance remains the cash‑cow, delivering 79% of underwriting margin and 67% of premium revenue. Life net sales grew 6% YoY to $1.27 billion, with premium revenue up 3% to $853.2 million. Health insurance, though smaller, posted remarkable 58% growth in net sales and contributed 21% of underwriting margin and 33% of premium revenue. Health premium revenue jumped 13% to $416.9 million, indicating a successful expansion of the company’s health portfolio.

*

Division‑Level Highlights

- American Income Life: Life underwriting margin rose 7%, premium +5%, net sales +3%; average producing agents up 9%.

- Liberty National: Life net sales up 13% and underwriting margin up 11%.

- Family Heritage: Health net sales surged 22%, underwriting margin +11%, premium +10%; agent count grew 10%.

- Direct to Consumer: Life underwriting margin jumped 15% with net sales up 8%.

- United American: Health net sales more than doubled from $28 M to ~$62 M, underwriting margin climbed from ~$2 M to $5 M, and premium rose 22%.

These results illustrate a balanced growth engine: life lines continue to provide stable cash flow, while health lines are accelerating, especially in the United American and Family Heritage divisions.

*

Expense Management

Administrative expenses held at 7.4% of premium, a slight uptick from 7.3% a year ago, suggesting that the cost of scaling health operations is being absorbed without eroding profitability. The modest rise is offset by higher underwriting margins, particularly in health, where margins expanded from roughly $2 M to $5 M in United American.

*

Guidance Upgrade

Management raised its FY26 EPS guidance to a $15.40‑$15.90 range, up $0.35 at the midpoint. The revision reflects confidence in continued premium growth, especially in health, and the expectation that underwriting margins will stay robust. No changes were made to the company’s dividend policy, and the share‑repurchase plan remains in place.

*

Market Reaction

Despite the earnings beat and guidance hike, GL’s stock moved only marginally higher (+0.19%) while the broader S&P 500 climbed 1.03% on the day. The modest price action suggests that investors had already priced in a degree of upside, but the guidance lift provided a catalyst for further upside as the stock now trades near the top of its 52‑week range (96%).

*

Outlook

Going forward, Globe Life’s key risk lies in maintaining health‑line momentum while controlling expense growth. The company’s strong agent recruitment—average producing agents up double‑digits in two divisions—should sustain premium expansion. If underwriting discipline holds, the FY26 EPS target appears attainable, and the ongoing share‑repurchase program could further compress the share count, enhancing per‑share metrics.

*

Bottom Line

Globe Life delivered a well‑executed quarter, beating expectations, expanding margins, and raising its earnings outlook. The blend of steady life‑insurance cash flow and rapid health‑insurance growth positions the insurer for a potentially stronger second half, provided expense discipline and underwriting quality persist.

*